MicroRNA-Regulated Rickettsial Invasion into Host Endothelium via Fibroblast Growth Factor 2 and Its Receptor FGFR1

被引:6
|
作者
Sahni, Abha [1 ]
Narra, Hema P. [1 ]
Patel, Jignesh [1 ]
Sahni, Sanjeev K. [1 ]
机构
[1] Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA
基金
美国国家卫生研究院;
关键词
miRNA; FGF2; FGFR1; Rickettsia; endothelial cells; SPOTTED-FEVER; INFECTION; ROLES; SURVIVAL; BIOLOGY; TARGET; CELLS; FORMS;
D O I
10.3390/cells7120240
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Microvascular endothelial cells (ECs) represent the primary target cells during human rickettsioses and respond to infection via the activation of immediate-early signaling cascades and the resultant induction of gene expression. As small noncoding RNAs dispersed throughout the genome, microRNAs (miRNAs) regulate gene expression post-transcriptionally to govern a wide range of biological processes. Based on our recent findings demonstrating the involvement of fibroblast growth factor receptor 1 (FGFR1) in facilitating rickettsial invasion into host cells and published reports suggesting miR-424 and miR-503 as regulators of FGF2/FGFR1, we measured the expression of miR-424 and miR-503 during R. conorii infection of human dermal microvascular endothelial cells (HMECs). Our results revealed a significant decrease in miR-424 and miR-503 expression in apparent correlation with increased expression of FGF2 and FGFR1. Considering the established phenomenon of endothelial heterogeneity and pulmonary and cerebral edema as the prominent pathogenic features of rickettsial infections, and significant pathogen burden in the lungs and brain in established mouse models of disease, we next quantified miR-424 and miR-503 expression in pulmonary and cerebral microvascular ECs. Again, R. conorii infection dramatically downregulated both miRNAs in these tissue-specific ECs as early as 30 min post-infection in correlation with higher FGF2/FGFR1 expression. Changes in the expression of both miRNAs and FGF2/FGFR1 were next confirmed in a mouse model of R. conorii infection. Furthermore, miR-424 overexpression via transfection of a mimic into host ECs reduced the expression of FGF2/FGFR1 and gave a corresponding decrease in R. conorii invasion, while an inhibitor of miR-424 had the expected opposite effect. Together, these findings implicate the rickettsial manipulation of host gene expression via regulatory miRNAs to ensure efficient cellular entry as the critical requirement to establish intracellular infection.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Study on the polymorphism of fibroblast growth facor receptor (FGFR1) in sheep
    Bai, Jun Yan
    Jia, Xiao Ping
    Yang, You Bing
    Pang, You. Zhi.
    Wang, Yu Qin
    INDIAN JOURNAL OF ANIMAL RESEARCH, 2017, 51 (05) : 856 - 859
  • [22] Regulation of fibroblast growth factor receptor-1 (Fgfr1) by thyroid hormone: Identification of a thyroid hormone response element in the murine fgfr1 promoter
    O'Shea, Patrick J.
    Guigon, Celine J.
    Williams, Graham R.
    Cheng, Sheue-Yann
    ENDOCRINOLOGY, 2007, 148 (12) : 5966 - 5976
  • [23] Fibroblast growth factor receptor 1 (FGFR1) is over-expressed in benign prostatic hyperplasia whereas FGFR2-IIIc and FGFR3 are not
    Boget, S
    Cereser, C
    Parvaz, P
    Leriche, A
    Revol, A
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (03) : 303 - 310
  • [24] The prevalence of fibroblast growth factor receptor-1 (FGFR1) mutations in patients with Kallmann syndrome.
    Gleason, JL
    Xu, N
    Layman, LC
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (02) : 235A - 235A
  • [25] Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck
    Clauditz, Till Sebastian
    Boettcher, Arne
    Hanken, Henning
    Borgmann, Kerstin
    Sauter, Guido
    Wilczak, Waldemar
    Grob, Tobias
    Muenscher, Adrian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (01) : 53 - 61
  • [26] Expression of fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3) in the developing head and face
    Wilke, TA
    Gubbels, S
    Schwartz, J
    Richman, JM
    DEVELOPMENTAL DYNAMICS, 1997, 210 (01) : 41 - 52
  • [27] Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck
    Till Sebastian Clauditz
    Arne Böttcher
    Henning Hanken
    Kerstin Borgmann
    Guido Sauter
    Waldemar Wilczak
    Tobias Grob
    Adrian Münscher
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 53 - 61
  • [28] Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement
    Umino, Kento
    Fujiwara, Shin-ichiro
    Ikeda, Takashi
    Toda, Yumiko
    Ito, Shoko
    Mashima, Kiyomi
    Minakata, Daisuke
    Nakano, Hirofumi
    Yamasaki, Ryoko
    Kawasaki, Yasufumi
    Sugimoto, Miyuki
    Yamamoto, Chihiro
    Ashizawa, Masahiro
    Hatano, Kaoru
    Sato, Kazuya
    Oh, Iekuni
    Ohmine, Ken
    Muroi, Kazuo
    Kanda, Yoshinobu
    HEMATOLOGY, 2018, 23 (08) : 470 - 477
  • [29] Fibroblast growth factor receptor 5 (FGFR5) is a co-receptor for FGFR1 that is up-regulated in beta-cells by cytokine-induced inflammation
    Regeenes, Romario
    Silva, Pamuditha N.
    Chang, Huntley H.
    Arany, Edith J.
    Shukalyuk, Andrey I.
    Audet, Julie
    Kilkenny, Dawn M.
    Rocheleau, Jonathan V.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (44) : 17218 - 17228
  • [30] Exploring The Role of Digital Pathology in Analysis of Fibroblast Growth Factor Receptor 1 (FGFR1) Profile in Liver Disease
    Imawana, R.
    Clegg, F.
    Thompson, D.
    McLean, M.
    Delibegovic, M.
    Murray, G.
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S40 - S40